Pharmacologic treatment of disorders of bladder and urethra: a review.
The use of pharmacologic agents in treating disorders of the bladder and proximal urethra has expanded because of new knowledge gained in the past few years. A better understanding of the properties of these organs as they relate to drugs has contributed to this expansion. The authors present their experience with a number of drugs in treating disorders of the detrusor muscle and proximal urethra, and they briefly review the literature.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D014522:Urethral Diseases / Q000188:drug therapy*; D014524:Urethral Obstruction / Q000188:drug therapy / Q000209:etiology; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D001750:Urinary Bladder, Neurogenic / Q000150:complications; D014549:Urinary Incontinence / Q000188:drug therapy
D000316:Adrenergic alpha-Agonists; D001626:Bethanechol Compounds; D010276:Parasympatholytics; D010643:Phenoxybenzamine